Inventor · disambiguated record
Zhixiang He
Also filed as: HE ZHIXIANG
11 granted patents·4 pending applications·6 citations·filing 2017–2024
80Inventor score
Files withDANA FARBER CANCER INST INC11ANHUI NEW STAR PHARMACEUTICAL DEV CO LTD1ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD1Allorion Therapeutics Inc1UNIV XIAMEN1
Top patents by PatentIndex Score
15 records- 0187US11530219B2Ligands to cereblon (CRBN)DANA FARBER CANCER INST INC·Filed 2019·Granted Dec 20, 2022·3 cites·15 claims
- 0278US11505560B2Heterobifunctional compounds with improved specificityDANA FARBER CANCER INST INC·Filed 2018·Granted Nov 22, 2022·2 cites·16 claims
- 0374US12110292B2Ligands to cereblon (CRBN)DANA FARBER CANCER INST INC·Filed 2022·Granted Oct 8, 2024·0 cites·16 claims
- 0468US11352354B2Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereofUNIV XIAMEN·Filed 2018·Granted Jun 7, 2022·1 cites·18 claims
- 0564US2024166635A1Aminoheteroaryl kinase inhibitorsANRUI BIOMEDICAL TECH GUANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0664US2025320185A1Aminoheteroaryl kinase inhibitorsAllorion Therapeutics Inc·Filed 2024·Application pending·0 cites
- 0756US12281126B2Inhibitors of cyclin-dependent kinase 7 and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Apr 22, 2025·0 cites·15 claims
- 0851US12491251B2Degraders of cyclin-dependent kinase 7 (CDK7) and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Dec 9, 2025·0 cites·25 claims
- 0951US12030892B2CRBN modulatorsDANA FARBER CANCER INST INC·Filed 2019·Granted Jul 9, 2024·0 cites·19 claims
- 1051US2023242534A9Inhibitors of cyclin-dependent kinase 7 and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1150US2023357222A1Selective small molecule degraders of cereblonDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1247US12509455B2Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Dec 30, 2025·0 cites·18 claims
- 1344US12234220B2Immunomodulatory compoundsDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 25, 2025·0 cites·42 claims
- 1444US12060366B2Bispecific degradersDANA FARBER CANCER INST INC·Filed 2019·Granted Aug 13, 2024·0 cites·20 claims
- 1523US10975092B2Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereofANHUI NEW STAR PHARMACEUTICAL DEV CO LTD·Filed 2017·Granted Apr 13, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Zhixiang He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →